Skip to main content
Home
Zeitschriften
Zeitungen
Podcast
Gesundheitspolitik
Praxis
Allerlei
Jobs
Fachgebiete
Allgemeinmedizin Anästhesiologie & Intensivmedizin Apotheke Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kinder & Jugendheilkunde Neurologie & Psychiatrie Orthopädie & Unfallchirurgie Pflege Urologie Zahnmedizin
Subfächer Innere Medizin
Diabetologie Gastroenterologie Infektiologie Kardiologie Onkologie und Hämatologie Pneumologie Rheumatologie
Fortbildungen
Überblick Fortbildungen DFP-Literaturstudium-Artikel DFP-Webcast Fortbildungen DFP-Podcasts
Erweiterte Suche
Anmelden
nach oben
neuropsychiatrie
Erschienen in:

22.09.2017 | übersicht

Suizidrisiko bei somatoformen Störungen

verfasst von: Giancarlo Giupponi, Ignazio Maniscalco, Sandra Mathà, Carlotta Ficco, Georg Pernther, Livia Sanna, Maurizio Pompili, Hans-Peter Kapfhammer, Andreas Conca

Erschienen in: neuropsychiatrie | Ausgabe 1/2018

Einloggen, um Zugang zu erhalten

Zusammenfassung

Grundlagen

Somatoforme Störungen umfassen eine Gruppe komplexer Störungen, die aus somatischen Symptomen besteht, für die es keine erkennbare organische Ursache oder pathogenetische Mechanismen gibt. Angesichts der Bedeutung dieser Erkrankung und der Notwendigkeit, die Diagnose einer somatoformen Störung und deren Auswirkung auf das Suizidrisiko zu erklären, haben wir wissenschaftliche Literatur miteinbezogen, um die Korrelation zwischen den beiden Faktoren zu untersuchen.

Methodik

Wir führten eine Literatursuche über Medline, Embase, PsycINFO, Scopus, SciELO, ORCID, Google Scholar, DOAJ durch und verwendeten dabei die folgenden englische Begriffe: somatoform, somatization disorder, pain disorder AND psychological factor, suicide, parasuicide, suicidality.

Ergebnisse

In all den Studien, die wir in unserer Revision erwähnt haben, zeigte sich, dass das Suizidrisiko erhöht ist. Aber beim Großteil sind die Daten relativ wenig verlässlich, wenn man die nosographische Kategorie „Angststörungen, Anpassungsstörungen und somatoforme Störungen“ berücksichtigt. Zu umfassend, zu breit gefächert, um klinische Charakteristiken der Risikopatienten mit ausschließlich somatoformer Störung zu erkennen.

Schlussfolgerungen

Mehrere Studien kommen zum Schluss, dass psychiatrische Komorbidität das Suizidrisiko erhöht: Patienten mit zwei oder mehr psychiatrischen Erkrankungen begehen eher einen Selbstmordversuch. Vor allem bei einer Diagnose der Achse I verdoppelt sich das Risiko. Die Somatisierungsstörung scheint eine signifikante psychiatrische Komorbidität zu haben, insbesondere mit dem Spektrum affektiver Störungen und Angststörungen.
Vorheriger Artikel Oxytocin und die suchterhaltenden Mechanismen der Alkoholabhängigkeit
Nächster Artikel Substance use and misuse among children and youth with mental illness
Literatur
1.
Centers for Disease Control and Prevention. MMWR Morb Mortal Wkly Rep 1998; 47. (CDC). Suicide among African-American youths – United, Bd. 1980. 1995. S. 193–6.
2.
Harris EC, Barraclough B. Suicide as an outcome for mental disorders. A meta-analysis. Br J Psychiatry. 1997;170:205–28.PubMedCrossRef
3.
Joe S, Baser RE, Breeden G, Neighbors HW, Jackson JS. Preval Risk Factors Lifetime Suicide Attempts Among Blacks United states Jama. 2006;296:2112–23.
4.
5.
Wasserman D, Cheng Q, Jiang GX. Global suicide rates among young people aged 15–19. World Psychiatry. 2005;4(2):114–20.PubMedPubMedCentral
6.
Hawton K, Appleby L, Platt S, Foster T, Cooper J, Malmberg A, Simkin S. The psychological autopsy approach to studying suicide: A review of methodological issues. J Affect Disord. 1998;50(2–3:269–76.
7.
Cavanagh JT, Carson AJ, Sharpe M, Lawrie SM. Psychological autopsy studies of suicide: a systematic review. Psychol Med. 2003;33:395–405.PubMedCrossRef
8.
9.
Harwood D, Hawton K, Hope T, Jacoby R. Suicide in older people without psychiatric disorder. Int J Geriatr Psychiatry. 2006;21(4):363–7.PubMedCrossRef
10.
Baxter D, Appleby L. Case register study of suicide risk in mental disorders. Br J Psychiatry. 1999;175:322–6.PubMedCrossRef
11.
Qin P, Nordentoft M. Suicide risk in relation to psychiatric hospitalization: evidence based on longitudinal registers. Arch Gen Psychiatry. 2005;62:427–32.PubMedCrossRef
12.
Chabrol H, Moron P. Depressive disorders in 100 adolescents who attempted suicide. Am J Psychiatry. 1988;145:379.PubMed
13.
Cole DA. Psychopathology of adolescent suicide: Hopelessness, coping beliefs, and depression. J Abnorm Psychol. 1989;98:248–55.PubMedCrossRef
14.
De Man AF. Correlates of suicide ideation in high school students. The importance of depression. J Genet Psychol. 1999;160:105–14.PubMedCrossRef
15.
Beck AT, Steer RA, Beck JS, Newman CF. Hopelessness, depression suicidal ideation, and clinical diagnosis of depression. Suicide Life Threat Behav. 1993;23:139–45.PubMed
16.
Marttunen MJ, Aro HM, Lonnqvist JK. Adolescent suicide: Endpoint of long-term difficulties. J Am Acad Child Adolesc Psychiatry. 1992;31:649–54.PubMedCrossRef
17.
Thompson AH. Younger onset of depression is associated with greater suicidal intent. Soc Psychiatry Psychiatr Epidemiol. 2008;43(7):538–44.PubMedCrossRef
18.
De Waal MW, Arnold IA, Eekhof JA, van Hemert AM. Somatoform disorders in general practice: prevalence, functional impairment and comorbidity with anxiety and depressive disorders. Br J Psychiatry. 2004;184:470–6.PubMedCrossRef
19.
Chang DF, Myers HF, Yeung A, Zhang Y, Zhao J, Yu S. Shenjing shuairuo and the DSM-IV: diagnosis, distress, and disability in a Chinese primary care setting. Transcult Psychiatry. 2005;42(2):204–18.PubMedCrossRef
20.
Leiknes KA, Finset A, Moum T, Sandanger I. Current somatoform disorders in Norway: prevalence, risk factors and comorbidity with anxiety, depression and musculoskeletal disorders. Soc Psychiatry Psychiatr Epidemiol. 2007;42:698–710.PubMedCrossRef
21.
Schaefert R, Hausteiner-Wiehle C, Häuser W, Ronel J, Herrmann M, Henningsen P. Non-specific, functional, and somatoform bodily complaints. Dtsch Arztebl Int. 2012;109((47):803–13.PubMedPubMedCentral
22.
Hiller W, Rief W, Brahler E. Somatization in the population: From mild bodily misperceptions to disabling symptoms. Soc Psychiatry Psychiatr Epidemiol. 2006;41(9):704–12.PubMedCrossRef
23.
Katon W, Kleinman A, Rosen G. Depression and somatization: a review, part 1. Am J Med. 1982;72:127–35.PubMedCrossRef
24.
Lesse S. Masked depression – the ubiquitous but unappreciated syndrome. Psychiatr J Univ Ott. 1980;5:268–73.
25.
Belous AR, Ramamoorthy S, Blakely RD, Factor MI, Dupin AM, Katasonov AB, Lozier RH, Beniashvili AG, Morozova MA, Brusov OS. The state of the serotonin transporter protein in the platelets of patients with somatoform disorders. Neurosci Behav Physiol. 2001;31:185–9.PubMedCrossRef
26.
Rost KM, Akins RN, Brown FW, Smith GR. The comorbidity of DSM-III-R personality disorders in somatization disorder. Gen Hosp Psychiatry. 1992;14(5):322–6.PubMedCrossRef
27.
Nijenhuis ER, Spinhoven P, van Dyck R, van der Hart O, Vanderlinden J. Degree of somatoform and psychological dissociation in depressive disorder is correlated with reported trauma. J Trauma Stress. 1998;11(4):711–30.PubMedCrossRef
28.
29.
Chioqueta AP, Stiles TC. Suicide risk in patients with somatization disorder. Crisis. 2004;25:3–7.PubMedCrossRef
30.
Mann JJ. A current perspective of suicide and attempted suicide. Ann Intern Med. 2002;136:302–11.PubMedCrossRef
31.
Schneider B, Georgi K, Weber B, Schnabel A, Ackermann H, Wetterling T. Risikofaktoren für Suizid bei Störungen im Zusammenhang mit psychotropen Substanzen. Psychiat Prax. 2006;33:81–7.CrossRef
32.
Pompili M, Di Cosimo D, Innamorati M, Lester D, Tatarelli R, Martelletti P. Psychiatric comorbidity in patients with chronic daily headache and migraine: a selective overview including personality traits and suicide risk. J Headache Pain. 2009;10:283–90.PubMedPubMedCentralCrossRef
33.
Ilgen MA, Zivin K, McCammon RJ, Valenstein M. Pain and suicidal thoughts, plans and attempts in the United States. Gen Hosp Psychiatry. 2008;30:521–7.PubMedPubMedCentralCrossRef
34.
Fishbain DA. The association of chronic pain and suicide. Semin Clin Neuropsychiatry. 1999;4(3):221–7.PubMed
35.
Parisi P. Migraine and suicidal ideation in adolescents aged 13 to 15 years. Neurology 2009;73:1713; author reply 1713–1714.
36.
Wang SJ, Juang KD, Fuh JL, Lu SR. Psychiatric comorbidity and suicide risk in adolescents with chronic daily headache. Neurology. 2007;68:1468–73.PubMedCrossRef
37.
Woolley SB, Fredman L, Goethe JW, Lincoln AK, Heeren T. Headache complaints and the risk of suicidal thoughts or behaviors. J Nerv Ment Dis. 2008;196:822–8.PubMedCrossRef
38.
Corruble E, Guelfi JD. Pain complaints in depressed inpatients. Psychopathology. 2000;33:307–9.PubMedCrossRef
39.
Kemper CJ, Lutz J, Bähr T, Rüddel H, Hock M. Construct Validity of the Anxiety Sensitivity Index–3 in Clinical Samples. Assessment. 2012;19:89–100.PubMedCrossRef
40.
Takahashi Y, Hirasawa H, Koyama K, Asakawa O, Kido M, Onose H, Udagawa M, Ishikawa Y, Uno M. Suicide and aging in Japan: an examination of treated elderly suicide attempters. Int Psychogeriatr. 1995;7:239–51.PubMedCrossRef
41.
Hennings A, Zill P, Rief W. Serotonin transporter gene promoter polymorphism and somatoform symptoms. J Clin Psychiatry. 2009;70:1536–9.PubMedCrossRef
42.
Horjales-Araujo E, Demontis D, Lund EK, Vase L, Finnerup NB, Børglum AD, Jensen TS, Svensson P. Emotional modulation of muscle pain is associated with polymorphisms in the serotonin transporter gene. Pain. 2013;154(8):1469–76.PubMedCrossRef
43.
Anguelova M, Benkelfat C, Turecki G. A systemic review of association studies investigating gene coding for serotonin receptors and the serotonin transporter, II: suicidal behavior. Mol Psychiatry. 2003;8(7):646–53. Jul.PubMedCrossRef
44.
Lin PY, Tsai G. Association between serotonin transporter gene promoter polymorphism and suicide: results of a meta-analysis. Biol Psychiatry. 2004;15;55(10):1023–30.CrossRef
45.
Li D, He L. Meta-analysis supports association between serotonin transporter (5HTT) and suicidal behavior. Mol Psychiatry. 2007;12:47–54.PubMedCrossRef
46.
Du L, Bakish D, Lapierre YD, Ravindran AV, Hrdina PD. Association of polymorphism of serotonin 2 A receptor gene with suicidal ideation in major depressive disorder. Am J Med Genet. 2000;7;96(1):56–60.CrossRef
47.
Oquendo MA, Mann JJ. Neuroimaging findings in major depression, suicidal behavior and aggression. Clin Neurosci Res. 2001;1:377–80.CrossRef
48.
Marazziti D, Dell’Osso L, Presta S, Pfanner C, Rossi A, Masala I, Baroni S, Giannaccini G, Lucacchini A, Platelet CGB. 3 H]paroxetine binding in patients with OCD-related disorders. Psychiatry Res. 1999;27;89(3):223–8.CrossRef
49.
Barr L, Goodman W, Price L. Acute exacerbation of body dysmorphic disorder during tryptophan depletion. Am J Psychiatry. 1992;149:1406–7.PubMed
50.
Barr L, Goodman WK, McDougle CJ, Delgado PL, Heninger GR, Charney DS, Price LH. Tryptophan depletion in patients with obsessive-compulsive disorder who respond to serotonin reuptake inhibitors. Arch Gen Psychiatry. 1994;51(4):309–17.PubMedCrossRef
51.
Smeraldi E, Diaferia G, Erzogovesi S. Tryptophan depletion in obsessive-compulsive patients. Biol Psychiatry. 1996;40:398–402.PubMedCrossRef
52.
Hanes K. Serotonin, psilocybin, and body dysmorphic disorder: a case report. J Clin Psychopharmacol. 1996;16(2):188–9. Apr.PubMedCrossRef
53.
Moreno FA, Delgado PL. Hallucinogen-induced relief of obsessions and compulsions. Am J Psychiatry. 1997;154:1037–8.PubMed
54.
Craven J, Rodin G. Cyproheptadine dependence associated with an atypical somatoform disorder. Can J Psychiatry. 1987;32:143–5.PubMedCrossRef
55.
Hollander E, Introduction WC. obsessive-compulsive spectrum disorders. J Clin Psychiatry. 1995;56:3–6.PubMed
56.
Perugi G, Giannotti D, Frare F, Di Vaio S, Valori E, Maggi L, Cassano GB, Akiskal HS. Prevalence, phenomenology and comorbidity of body dysmorphic disorder (dysmorphophobia) in a clinical population. Int J Clin Pract. 1997;1:77–82.CrossRef
57.
Phillips KA, Albertini RS, Rasmussen SA. A randomized placebo-controlled trial of fluoxetine in body dysmorphic disorder. Arch Gen Psychiatry. 2002;59:381–8.PubMedCrossRef
58.
Phillips KA, Dwight MM, McElroy SL. Efficacy and safety of fluvoxamine in body dysmorphic disorder. J Clin Psychiatry. 1998;59:165–71.PubMedCrossRef
59.
Phillips KA, Najjar F. An open-label study of citalopram in body dysmorphic disorder. J Clin Psychiatry. 2003;64:715–20.PubMedCrossRef
60.
Hayashi N, Igarashi M, Imai A, Osawa Y, Utsumi K, Ishikawa Y, Tokunaga T, Ishimoto K, Harima H, Tatebayashi Y, Kumagai N, Nozu M, Ishii H, Okazaki Y. Psychiatric disorders and clinical correlates of suicidal patients admitted to a psychiatric hospital in Tokyo. BMC Psychiatry. 2010;13;10:109.CrossRef
61.
Rudd MD, Dahm PD, Rajab MH. Diagnostic comorbidity in persons with suicidal ideation and behavior. Am J Psychiatry. 1993;150:928–34.PubMedCrossRef
62.
McDermut W, Mattia J, Zimmerman M. Comorbidity burden and its impact on psychosocial morbidity in depressed outpatients. J Affect Disord. 2001;65((3):289–95.PubMedCrossRef
63.
Henriksson MM, Aro HM, Marttunen MJ, Heikkinen ME, Isometsä ET, Kuoppasalmi KI, Lönnqvist JK. Mental disorders and comorbidity in suicide. Am J Psychiatry. 1993;150:935–40.PubMedCrossRef
64.
Arsenault-Lapierre G, Kim C, Turecki G. Psychiatric diagnoses in 3275 suicides: a meta-analysis. BMC Psychiatry. 2004;4; 4:37.PubMedCrossRef
65.
Sar V, Akyüz G, Kundakçi T, Kiziltan E, Dogan O. Childhood trauma, dissociation, and psychiatric comorbidity in patients with conversion disorder. Am J Psychiatry. 2004;161(12):2271–6.PubMedCrossRef
66.
Guz H, Doganay Z, Ozkan A, Colak E, Tomac A, Sarisoy G. Conversion and somatization disorders; dissociative symptoms and other characteristics. J Psychosom Res. 2004;56(3):287–91.PubMedCrossRef
67.
Foote B, Smolin Y, Neft DI, Lipschitz D. Dissociative disorders and suicidality in psychiatric outpatients. J Nerv Ment Dis. 2008;196(1):29–36.PubMedCrossRef
68.
Akyuz G, Sar V, Kugu N, Doğan O. Reported childhood trauma, attempted suicide and self-mutilative behavior among women in the general population. Eur Psychiatry. 2005;20(3):268–73.PubMedCrossRef
69.
Na KS, Oh SJ, Jung HY, Lee IS, Kim YK, Han C, Ko YH, Paik JW, Kim SG. Alexithymia and low cooperativeness are associated with suicide attempts in male military personnel with adjustment disorder: a case-control study. Psychiatry Res. 2013;205(3):220–6.PubMedCrossRef
70.
Mitsui N, Asakura S, Inoue T, Shimizu Y, Fujii Y, Kako Y, Tanaka T, Kitagawa N, Kusumi I. Temperament and character profiles of Japanese university student suicide completers. Compr Psychiatry. 2013;54(5):556–61.PubMedCrossRef
71.
Perroud N, Baud P, Ardu S, Krejci I, Mouthon D, Vessaz M, Guillaume S, Jaussent I, Olié E, Malafosse A, Courtet P. Temperament personality profiles in suicidal behaviour: an investigation of associated demographic, clinical and genetic factors. J Affect Disord. 2013;146(2):246–53.PubMedCrossRef
72.
Giegling I, Olgiati P, Hartmann AM, Calati R, Möller HJ, Rujescu D, Serretti A. Personality and attempted suicide. Analysis of anger, aggression and impulsivity. J Psychiatr Res. 2009;43(16):1262–71.PubMedCrossRef
73.
Güleç MY, Ýnanç L, Yanartaþ Ö, Üzer A, Güleç H. Predictors of suicide in patients with conversion disorder. Compr Psychiatry. 2014;55(3):457–62.PubMedCrossRef
74.
Linehan M, Nielsen S. Assessment of suicide ideation and parasuicide: hopelessness and social desirability. J Consult Clin Psychol. 1981;49(5):773–5.PubMedCrossRef
75.
Sartorius N, Ustün TB, Costa de Silva JA, Goldberg D, Lecrubier Y, Ormel J. An international study of psychological problems in primary care: preliminary report from the World Health Organisation project on psychological problems in general health care. Arch Gen Psychiatry. 1993;50:819–24.PubMedCrossRef
76.
Park S, Cho MJ, Seong S, Shin SY, Sohn J, Hahm BJ, Hong JP. Psychiatric morbidities, sleep disturbances, suicidality, and quality-of-life in a community population with medically unexplained pain in Korea. Psychiatry Res. 2012;198(3):509–15.PubMedCrossRef
77.
Lecrubier Y. The influence of comorbidity on the prevalence of suicidal behaviour. Eur Psychiatry. 2001;16(7):395–9.PubMedCrossRef
78.
Henningsen P, Zimmermann T, Sattel H. Medically unexplained physical symptoms, anxiety, and depression: A meta-analytic review. Psychosom Med. 2003;65(4):528–33.PubMedCrossRef
79.
Lowe B, Spitzer RL, Williams JB, Mussell M, Schellberg D, Kroenke K. Depression, anxiety and somatization in primary care: Syndrome overlap and functional impairment. Gen Hosp Psychiatry. 2008;30(3):191–9.PubMedCrossRef
80.
Wiborg JF, Gieseler D, Fabisch AB, Voigt K, Lautenbach A, Löwe B. Suicidality in primary care patients with somatoform disorders. Psychosom Med. 2013;75(9):800–6.PubMedCrossRef
81.
Fliege H, Lee JR, Grimm A, Klapp BF. Risk factors and correlates of deliberate self-harm behavior: a systematic review. J Psychosom Res. 2009;66((6):477–93.PubMedCrossRef
82.
Breslau N, Davis GC, Andreski P. Migraine, psychiatric disorders, and suicide attempts: an epidemiologic study of young adults. Psychiatry Res. 1991;37:11–23.PubMedCrossRef
83.
Ratcliffe GE, Enns MW, Belik SL, Sareen J. Chronic pain conditions and suicidal ideation and suicide attempts: an epidemiologic perspective. Clin J Pain. 2008;24:204–10.PubMedCrossRef
84.
Breslau N, Lipton RB, Stewart WF, Schultz LR, Welch KMA. Comorbidity of migraine and depression: investigating potential etiology and prognosis. Neurology. 2003;60:1308–12.PubMedCrossRef
85.
Tang N, Crane C. Suicidality in chronic pain: a review of the prevalence risk factors and psychological links. Psychol Med. 2006;36:575–86.PubMedCrossRef
86.
Fishbain DA, Goldberg M, Rosomoff RS, Rosomoff H. Completed suicide in chronic pain. Clin J Pain. 1991;7:29–36.PubMedCrossRef
87.
88.
89.
Hinkley BS, Jaremko ME. Effects of pain duration on psychosocial adjustment in orthopedic patients: the importance of early diagnosis and treatment of pain. J Pain Symptom Manage. 1994;9:175–85.PubMedCrossRef
90.
Edwards RR, Smith MT, Kudel I, Haythornthwaite J. Pain-related catastrophizing as a risk factor for suicidal ideation in chronic pain. Pain. 2006;126:272–9.PubMedCrossRef
91.
Saffier K, Colombo C, Brown D, Mundt MP, Fleming MF. Addiction Severity Index in a chronic pain sample receiving opioid therapy. J Subst Abuse Treat. 2007;33:303–11.PubMedPubMedCentralCrossRef
92.
Magni G, Rigatti-Luchini S, Fracca F, Merskey H. Suicidality in chronic abdominal pain: an analysis of the Hispanic Health and Nutrition Examination Survey (HHANES). Pain. 1998;76:137–44.PubMedCrossRef
93.
Hitchcock LS, Ferrell BR, McCaffery M. The experience of chronic non malignant pain, J. Pain Sympt. Manage. Afr J Med Med Sci. 1994;9:312:318.
Metadaten
Titel
Suizidrisiko bei somatoformen Störungen
verfasst von
Giancarlo Giupponi
Ignazio Maniscalco
Sandra Mathà
Carlotta Ficco
Georg Pernther
Livia Sanna
Maurizio Pompili
Hans-Peter Kapfhammer
Andreas Conca
Publikationsdatum
22.09.2017
Verlag
Springer Vienna
Erschienen in
neuropsychiatrie / Ausgabe 1/2018
Print ISSN: 0948-6259
Elektronische ISSN: 2194-1327
DOI
https://doi.org/10.1007/s40211-017-0248-8

Weitere Artikel der Ausgabe 1/2018

Oxytocin und die suchterhaltenden Mechanismen der Alkoholabhängigkeit

  • Open Access
  • review

Relevanz von Erkrankungsart und beruflichem Status für die Ergebnisse psychiatrischer Rehabilitation

  • originalarbeit

„Wer aber ist Johann Hauser?“

  • kultur im kontext

Bericht aus dem Vorstand

  • bericht aus dem ögpp-vorstand

Maternal bonding behavior, adult intimate relationship, and quality of life

  • Open Access
  • original article

Bericht aus dem Präsidium der ÖGKJP

  • bericht aus dem ögkjp-vorstand